Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingyu Du

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Medicine|October 12, 2022
Novel nomograms predicting the survival of patients with nonsurgical thoracic esophageal squamous cell carcinoma treated with IMRT: A retrospective analysisXingyu Du, Jing Dong, Ke Yan, et al.
BMC Medical Genomics|February 21, 2023
A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinomaDong Guo, Xueyuan Zhang, Xingyu Du, et al.
Scientific Reports|January 21, 2018
Design of non-equiatomic medium-entropy alloysYang Zhou, Dong Zhou, Xi Jin, et al.
Discover Oncology|May 26, 2023
NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathwayDong Guo, Weinan Yao, Xingyu Du, et al.
Thoracic Cancer|December 18, 2025
Predictive Value of the Estimated Dose of Radiation to Immune Cells Versus Conventional Parameters in Elderly Patients With Unresectable Stage III NSCLC: A Two-Center Real-World StudyHuan Li, Xingyu Du, Song Guan, et al.
Chemsuschem|September 14, 2022
Three-Dimensional Holey Graphene Enwrapped Li<sub>3</sub> V<sub>2</sub> (PO<sub>4</sub> )<sub>3</sub> /N-Doped Carbon Cathode for High-Rate and Long-Life Li-Ion BatteriesXiaopeng Li, Xingyu Du, Yulin Xu, et al.
Cancer Immunology, Immunotherapy : CII|July 21, 2025
Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in patients with resectable stage III NSCLC? A two-center real-world studySong Guan, Hui Wang, Zhaoxin Chen, et al.
Cancer Cell International|April 28, 2020
Lattice complex assembled by noncompetitive anti-EGFR antibodies regulates actin cytoskeletal reorganizationDianshuai Huang, Tianqi Lu, Xingyu Du, et al.
Antioxidants (Basel, Switzerland)|August 28, 2025
Gut Microbiota and Its Metabolites Modulate Pregnancy Outcomes by Regulating Placental Autophagy and FerroptosisXingyu Du, Mabrouk Elsabagh, Feiyang He, et al.
Journal of Cancer|July 11, 2022
HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCCJing Dong, Xueyuan Zhang, Xingyu Du, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Medicine|October 12, 2022
Novel nomograms predicting the survival of patients with nonsurgical thoracic esophageal squamous cell carcinoma treated with IMRT: A retrospective analysisXingyu Du, Jing Dong, Ke Yan, et al.
BMC Medical Genomics|February 21, 2023
A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinomaDong Guo, Xueyuan Zhang, Xingyu Du, et al.
Scientific Reports|January 21, 2018
Design of non-equiatomic medium-entropy alloysYang Zhou, Dong Zhou, Xi Jin, et al.
Discover Oncology|May 26, 2023
NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathwayDong Guo, Weinan Yao, Xingyu Du, et al.
Thoracic Cancer|December 18, 2025
Predictive Value of the Estimated Dose of Radiation to Immune Cells Versus Conventional Parameters in Elderly Patients With Unresectable Stage III NSCLC: A Two-Center Real-World StudyHuan Li, Xingyu Du, Song Guan, et al.
Chemsuschem|September 14, 2022
Three-Dimensional Holey Graphene Enwrapped Li<sub>3</sub> V<sub>2</sub> (PO<sub>4</sub> )<sub>3</sub> /N-Doped Carbon Cathode for High-Rate and Long-Life Li-Ion BatteriesXiaopeng Li, Xingyu Du, Yulin Xu, et al.
Cancer Immunology, Immunotherapy : CII|July 21, 2025
Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in patients with resectable stage III NSCLC? A two-center real-world studySong Guan, Hui Wang, Zhaoxin Chen, et al.
Cancer Cell International|April 28, 2020
Lattice complex assembled by noncompetitive anti-EGFR antibodies regulates actin cytoskeletal reorganizationDianshuai Huang, Tianqi Lu, Xingyu Du, et al.
Antioxidants (Basel, Switzerland)|August 28, 2025
Gut Microbiota and Its Metabolites Modulate Pregnancy Outcomes by Regulating Placental Autophagy and FerroptosisXingyu Du, Mabrouk Elsabagh, Feiyang He, et al.
Journal of Cancer|July 11, 2022
HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCCJing Dong, Xueyuan Zhang, Xingyu Du, et al.
Pageof 4